Directa SIM SpA
F:ZP7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Directa SIM SpA
Cost of Revenue
Directa SIM SpA
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Directa SIM SpA
F:ZP7
|
Cost of Revenue
-€6.7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Equita Group SpA
MIL:EQUI
|
Cost of Revenue
-€7.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Banca Profilo SpA
MIL:PRO
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Directa SIM SpA
Glance View
DIRECTA SIMpA is a financial brokerage company. The company is headquartered in Torino, Torino and currently employs 74 full-time employees. The company went IPO on 2021-12-22. The firm offers everyone the freedom to invest independently through user-friendly technology. The firm's aim is to allow private investors to operate on financial markets.
See Also
What is Directa SIM SpA's Cost of Revenue?
Cost of Revenue
-6.7m
EUR
Based on the financial report for Dec 31, 2025, Directa SIM SpA's Cost of Revenue amounts to -6.7m EUR.
What is Directa SIM SpA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%
Over the last year, the Cost of Revenue growth was -12%. The average annual Cost of Revenue growth rates for Directa SIM SpA have been -7% over the past three years , -6% over the past five years .
